We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
21.7
quarters
Top 10 Avg Time Held
6.6
quarters
Top 20 Avg Time Held
9.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2001
SoundHound AI
SOUN
$2.39B
| $966 | ﹤0.01% |
90
-616
| -87% | -$5.8K |
2024 Q4
2 quarters
|
|
2002
nLIGHT
LASR
$2.22B
| $964 | ﹤0.01% |
+49
| New | +$609 |
2025 Q2
0 quarters
|
|
2003
Ameren
AEE
$28.3B
| $960 | ﹤0.01% |
10
-121
| -92% | -$11.7K |
2025 Q1
1 quarter
|
|
2004
ASP Isotopes
ASPI
$406M
| $949 | ﹤0.01% |
+129
| New | +$865 |
2025 Q2
0 quarters
|
|
2005
Robert Half
RHI
$3.47B
| $944 | ﹤0.01% |
23
-21
| -48% | -$957 |
2013 Q2
48 quarters
|
|
2006
Nebius Group N.V.
NBIS
$60.1B
| $941 | ﹤0.01% |
17
| – | – |
2025 Q1
1 quarter
|
|
2007
CytomX Therapeutics
CTMX
$560M
| $903 | ﹤0.01% |
+398
| New | +$642 |
2025 Q2
0 quarters
|
|
2008
American Coastal Insurance
ACIC
$462M
| $878 | ﹤0.01% |
79
-35
| -31% | -$386 |
2024 Q1
5 quarters
|
|
2009
Velocity Financial
VEL
$582M
| $853 | ﹤0.01% |
46
-1,220
| -96% | -$21.4K |
2024 Q2
4 quarters
|
|
2010
Skye Bioscience
SKYE
$7.48M
| $823 | ﹤0.01% |
+25
| New | +$414 |
2025 Q2
0 quarters
|
|
2011
Star Equity Holdings
STRR
$38.1M
| $800 | ﹤0.01% |
94
| – | – |
2021 Q3
15 quarters
|
|
2012
DocGo
DCGO
$33.5M
| $796 | ﹤0.01% |
+507
| New | +$945 |
2025 Q2
0 quarters
|
|
2013
Comtech Telecommunications
CMTL
$35.4M
| $784 | ﹤0.01% |
320
-85
| -21% | -$153 |
2022 Q2
12 quarters
|
|
2014
DELISTED
Trinseo
TSE
| $752 | ﹤0.01% |
241
| – | – |
2024 Q3
3 quarters
|
|
2015
Rallybio
RLYB
$90.4M
| $747 | ﹤0.01% |
276
| – | – |
2024 Q1
5 quarters
|
|
2016
1st Source
SRCE
$2.02B
| $745 | ﹤0.01% |
12
| – | – |
2017 Q3
31 quarters
|
|
2017
Harvard Bioscience
HBIO
$37.5M
| $735 | ﹤0.01% |
166
| – | – |
2025 Q1
1 quarter
|
|
2018
RCM Technologies
RCMT
$294M
| $731 | ﹤0.01% |
31
-25
| -45% | -$503 |
2024 Q4
2 quarters
|
|
2019
Black Diamond Therapeutics
BDTX
$105M
| $722 | ﹤0.01% |
+291
| New | +$561 |
2025 Q2
0 quarters
|
|
2020
Nature's Sunshine
NATR
$222M
| $710 | ﹤0.01% |
+48
| New | +$649 |
2025 Q2
0 quarters
|
|
2021
First Western Financial
MYFW
$291M
| $699 | ﹤0.01% |
+31
| New | +$640 |
2025 Q2
0 quarters
|
|
2022
MarketWise
MKTW
$53.8M
| $693 | ﹤0.01% |
+35
| New | +$537 |
2025 Q2
0 quarters
|
|
2023
Bandwidth Inc
BAND
$1.71B
| $684 | ﹤0.01% |
+43
| New | +$584 |
2025 Q2
0 quarters
|
|
2024
Whitehawk Therapeutics
WHWK
$201M
| $669 | ﹤0.01% |
358
-572
| -62% | -$996 |
2023 Q4
6 quarters
|
|
2025
Amneal Pharmaceuticals
AMRX
$6.93B
| $655 | ﹤0.01% |
81
-272,990
| -100% | -$2.06M |
2023 Q3
7 quarters
|
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.